Advanced Search

Home > Journals > The Journal of Cardiovascular Surgery > Past Issues > The Journal of Cardiovascular Surgery 2013 October;54(5) > The Journal of Cardiovascular Surgery 2013 October;54(5):589-93

ISSUES AND ARTICLES   MOST READ   eTOC

CURRENT ISSUETHE JOURNAL OF CARDIOVASCULAR SURGERY

A Journal on Cardiac, Vascular and Thoracic Surgery

Indexed/Abstracted in: BIOSIS Previews, Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,632

Frequency: Bi-Monthly

ISSN 0021-9509

Online ISSN 1827-191X

 

The Journal of Cardiovascular Surgery 2013 October;54(5):589-93

NEW DEVELOPMENTS IN THE MANAGEMENT OF ABDOMINAL AORTIC ANEURYSMS 

    REVIEWS

Influence of gender on EVAR outcomes with new low-profile devices

Bendermacher B. L. W. 1, Grootenboer N. 2, Cuypers W. 1, Teijink J. A. W. 1, 3, Van Sambeek M. R. H. M. 1

1 Division of Vascular Surgery, Department of Surgery Catharina Hospital, Eindhoven, The Netherlands;
2 Department of Vascular Surgery Rigshospitalet, Copenhagen, Denmark;
3 Department of Epidemiology CAPHRI Research School, Maastricht University Maastricht, The Netherlands

Women have not benefitted to the same extent as men of endovascular abdominal aortic repair (EVAR). Besides differences in hormones and the higher rate of undiagnosed cardiovascular disease, there are anatomical differences between men and women influencing the outcome of endovascular treatment of abdominal aortic aneurysms (AAA). After the first decade of EVAR procedures, only 28% of women with an elective AAA were treated by EVAR due to their poor anatomical suitability for this technique. The anatomical challenges and their associated poorer outcomes suggest the need for advances in device design to better meet the specific female aneurysm anatomy and physiology. Most of the newer-generation endografts have been associated with lower incidences of graft occlusion compared with first-generation endografts, and might be more suitable for women. It is encouraging that EVAR has decreased long-term mortality in women and that women’s survival begins to equal men’s after 2 years. However, detailed, adjusted anatomical data from population-based samples are needed for better understanding of the differences in AAA anatomy and EVAR eligibility. This information will contribute to enhance the design, testing and evaluation of future stent grafts, to ensure that women will benefit from EVAR to the same extent as men.

language: English


FULL TEXT  REPRINTS

top of page